Asahi Kasei Corp, Japan’s leading diversified chemical manufacturer with businesses in the health care, chemicals & fibers, homes & construction materials, and electronics sectors, announced today the successful completion of its acquisition of ZOLL Medical Corp, a major U.S. manufacturer of medical devices for critical care.
On March 12, Asahi Kasei announced a tender offer for shares of ZOLL, through a US subsidiary. All procedures related to this acquisition were completed on April 26, 2012, US Eastern time, and ZOLL became a wholly owned consolidated subsidiary of Asahi Kasei.
As a result, ZOLL’s stock will cease to be traded on the NASDAQ market, and ZOLL will no longer have reporting obligations under the Securities Exchange Act of 1934. ZOLL will continue to be managed by its current management team.
© Business Wire
No Comment
Login to comment